Development of a lauric acid/albumin hybrid iron oxide nanoparticle system with improved biocompatibility

International Journal of Nanomedicine

Volumn 9, Issue , 2014, Pages 4847-4866

  Zaloga, Jan ^a   Janko, Christina ^a   Nowak, Johannes ^b   Matuszak, Jasmin ^a   Knaup, Sabine ^a   Eberbeck, Dietmar ^c   Tietze, Rainer ^a   Unterweger, Harald ^a   Friedrich, Ralf P ^a   Duerr, Stephan ^a   Heimke Brinck, Ralph ^a   Baum, Eva ^a   Cicha, Iwona ^a   Dörje, Frank ^a   Odenbach, Stefan ^b   Lyer, Stefan ^a   Lee, Geoffrey ^d   Alexiou, Christoph ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c PHYSIKALISCH TECHNISCHE BUNDESANSTALT   (Germany)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Colloidal stability; Drug delivery; Iron oxide nanoparticles; Magnetic drug targeting; Protein corona

Indexed keywords

ALBUMIN; BOVINE SERUM ALBUMIN; LAURIC ACID; MITOXANTRONE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; BIOMATERIAL; COLLOID; EDETIC ACID; LAURIC ACID DERIVATIVE; MAGNETITE NANOPARTICLE;

ARTICLE; BIOCOMPATIBILITY; CELL STRUCTURE; CELL VIABILITY; CHEMICAL COMPOSITION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; FLOW CYTOMETRY; GOOD MANUFACTURING PRACTICE; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; LIGHT SCATTERING; MATERIAL COATING; STRUCTURE ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; ANIMAL; BOVINE; CELL SURVIVAL; CHEMISTRY; COLLOID; DRUG EFFECTS; DRUG STABILITY; JURKAT CELL LINE; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; BIOCOMPATIBLE MATERIALS; CATTLE; CELL SURVIVAL; COLLOIDS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EDETIC ACID; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; JURKAT CELLS; LAURIC ACIDS; MAGNETITE NANOPARTICLES; MITOXANTRONE; SERUM ALBUMIN, BOVINE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84928380991     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S68539     Document Type: Article

References (31)

1. Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials. 2005; 26(18): 3995-4021.
2. Wadajkar AS, Menon JU, Kadapure T, Tran RT, Yang J, Nguyen KT. Design and application of magnetic-based theranostic nanoparticle systems. Recent Pat Biomed Eng. 2013; 6(1): 47-57.
3. Lu AH, Salabas EL, Schuth F. Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew Chem Int Ed Engl. 2007; 46(8): 1222-1244.
4. Tóth IY, Illés E, Bauer RA, et al. Designed polyelectrolyte shell on magnetite nanocore for dilution-resistant biocompatible magnetic fluids. Langmuir. 2012; 28(48): 16638-16646.
5. Albanese A, Tang PS, Chan WC. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng. 2012; 14: 1-16.
6. Sharma A, Madhunapantula SV, Robertson GP. Toxicological considerations when creating nanoparticle-based drugs and drug delivery systems. Expert Opin Drug Metab Toxicol. 2012; 8(1): 47-69.
7. Hanini A, Schmitt A, Kacem K, Chau F, Ammar S, Gavard J. Evaluation of iron oxide nanoparticle biocompatibility. Int J Nanomedicine. 2011; 6: 787-794.
8. Zauner W, Farrow NA, Haines AM. In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density. J Control Release. 2001; 71(1): 39-51.
9. Sun Z, Yathindranath V, Worden M, et al. Characterization of cellular uptake and toxicity of aminosilane-coated iron oxide nanoparticles with different charges in central nervous system-relevant cell culture models. Int J Nanomedicine. 2013; 8: 961-970.
10. Hang J, Shi L, Feng X, Xiao L. Electrostatic and electrosteric stabilization of aqueous suspensions of barite nanoparticles. Powder Technol. 2009; 192(2): 166-170.
11. Verwey E, Overbeek J. Theory of the Stability of Lyophobic Colloids. Amsterdam: Elsevier; 1948.
12. Bica D, Vékás L, Avdeev MV, et al. Sterically stabilized water based magnetic fluids: synthesis, structure and properties. J Magn Magn Mater. 2007; 311(1): 17-21.
13. Shen L, Laibinis PE, Hatton TA. Bilayer surfactant stabilized magnetic fluids: synthesis and interactions at interfaces. Langmuir. 1998; 15(2): 447-453.
14. Tietze R, Lyer S, Dürr S, et al. Efficient drug-delivery using magnetic nanoparticles-biodistribution and therapeutic effects in tumour bearing rabbits. Nanomedicine. 2013; 9(7): 961-971.
15. Alexiou C, Jurgons R, Schmid RJ, et al. Magnetic drug targeting-biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment. J Drug Target. 2003; 11(3): 139-149.
16. Gebauer JS, Malissek M, Simon S, et al. Impact of the nanoparticle-protein corona on colloidal stability and protein structure. Langmuir. 2012; 28(25): 9673-9679.
17. Lesniak A, Fenaroli F, Monopoli MP, Åberg C, Dawson KA, Salvati A. Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano. 2012; 6(7): 5845-5857.
18. Goodman DS. The interaction of human serum albumin with long-chain fatty acid anions. J Am Chem Soc. 1958; 80(15): 3892-3898.
19. Dokuzovic D. Kolorimetrie-Photometrie [Colorimetry-Photometry]. [webpage available on the Internet]. Available from: http: //www. lickl. net/doku/photo. pdf. Accessed June 8, 2014. German.
20. Tietze R, Schreiber E, Lyer S, Alexiou C. Mitoxantrone loaded superparamagnetic nanoparticles for drug targeting: a versatile and sensitive method for quantification of drug enrichment in rabbit tissues using HPLC-UV. J Biomed Biotechnol. 2010; 2010: 597304.
21. Kroll A, Pillukat MH, Hahn D, Schnekenburger J. Interference of engineered nanoparticles with in vitro toxicity assays. Arch Toxicol. 2012; 86(7): 1123-1136.
22. Munoz LE, Maueroder C, Chaurio R, Berens C, Herrmann M, Janko C. Colourful death: six-parameter classification of cell death by flow cytometry-dead cells tell tales. Autoimmunity. 2013; 46(5): 336-341.
23. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods. 1991; 139(2): 271-279.
24. Zucker RM, Daniel KM. Detection of TiO2 nanoparticles in cells by flow cytometry. Methods Mol Biol. 2012; 906: 497-509.
25. Zhang B, Li Q, Yin P, et al. Ultrasound-triggered BSA/SPION hybrid nanoclusters for liver-specific magnetic resonance imaging. ACS Appl Mater Interfaces. 2012; 4(12): 6479-6486.
26. Salgin S, Salgın U, Bahadir S. Zeta potentials and isoelectric points of biomolecules: the effects of ion types and ionic strengths. Int J Electrochem Sci. 2012; 7(12): 12404-12414.
27. Hunt CP, Singer MJ, Kletetschka G, TenPas J, Verosub KL. Effect of citrate-bicarbonate-dithionite treatment on fine-grained magnetite and maghemite. Earth Planet Sc Lett. 1995; 130(1-4): 87-94.
28. 2 magnetic nanocomposite via sol-gel matrix-mediated synthesis. J Appl Phys. 1997; 81(10): 6892-6900.
29. Hinderliter PM, Minard KR, Orr G, et al. ISDD: a computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies. Part Fibre Toxicol. 2010; 7(1): 36.
30. Faulds D, Balfour J, Chrisp P, Langtry H. Mitoxantrone. Drugs. 1991; 41(3): 400-449.
31. Asamura M, Yokoyama M, Kanamaru R, et al. [In vivo antitumor activity of mitoxantrone and the flow cytometric analysis of its influence on cell cycle transition-comparison with doxorubicin and aclarubicin on ascitic hepatoma AH109A cells]. Gan to Kagaku Ryoho. 1989; 16(12): 3769-3776. Japanese.